Archive for October 30th, 2008

New HIV Drug Commercially Available

A new class of HIV drugs called integrase inhibitors aims to help control the virus among untreated patients is now available. Merck and Co. has just presented its drug Isentress (generic name raltegravir), the first drug on the market in this new class. Isentress is being sold as a twice-a-day pill. Researchers told during a meeting of the American Society of Microbiology and the Infectious Disease Society of America that they have discovered that Isentress works slightly better compared to a…